Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy Grant US-11466324-B2 United States of America 11 Oct 2022
Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy Grant US-10208349-B2 United States of America 19 Feb 2019
Method for the treatment of multiple sclerosis by inhibiting IL-17 activity Grant US-7931900-B2 United States of America 26 Apr 2011